Appalachian Regional Healthcare

Hazard, Kentucky 41701

0 studies enrolling now · 3 studies all time

What they study most

Amyloidosis, EGFRI Induced Acneiform Lesions, Lymphoma, Multiple Myeloma

Studies at this site

• Ixazomib Rollover Study — Completed
• LUT014 for the Reduction of Dose-Limiting Acneiform Lesions Associated With EGFRI Treatment of mCRC — Status unconfirmed
• A Study of Oral Ixazomib Maintenance Therapy in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Not Treated With Stem Cell Transplantation (SCT) — Completed